The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis

被引:0
|
作者
Zhi Dong Zhou
Wuan Ting Saw
Patrick Ghim Hoe Ho
Zhi Wei Zhang
Li Zeng
Ya Yin Chang
Alfred Xu Yang Sun
Dong Rui Ma
Hong Yan Wang
Lei Zhou
Kah Leong Lim
Eng-King Tan
机构
[1] National Neuroscience Institute,Department of Neurology, Singapore General Hospital
[2] National Neuroscience Institute,Duke
[3] Signature Research Program in Neuroscience and Behavioural Disorders,NUS Graduate Medical School
[4] Singapore Eye Research Institute,Ocular Proteomics Laboratory
[5] National University of Singapore,Department of Ophthalmology, Yong Loo Lin School of Medicine
[6] Ophthalmology and Visual Sciences Academic Clinical Research Program,Developmental of Stem Cell Biology and Regenerative Medicine, Lee Kong Chian School of Medicine
[7] Duke-NUS Medical School,undefined
[8] Nanyang Technological University,undefined
来源
关键词
Dopamine; LRRK2; Neurodegeneration; Parkinson’s disease; PINK1; Tyrosine hydroxylase;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
    Toshiharu Nagatsu
    Akira Nakashima
    Hirohisa Watanabe
    Shosuke Ito
    Kazumasa Wakamatsu
    Fabio A. Zucca
    Luigi Zecca
    Moussa Youdim
    Maximilian Wulf
    Peter Riederer
    Johannes M. Dijkstra
    Journal of Neural Transmission, 2023, 130 : 611 - 625
  • [22] The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease
    Nagatsu, Toshiharu
    Nakashima, Akira
    Watanabe, Hirohisa
    Ito, Shosuke
    Wakamatsu, Kazumasa
    Zucca, Fabio A.
    Zecca, Luigi
    Youdim, Moussa
    Wulf, Maximilian
    Riederer, Peter
    Dijkstra, Johannes M.
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (05) : 611 - 625
  • [23] Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease
    Joyce, JN
    Smutzer, G
    Whitty, CJ
    Myers, A
    Bannon, MJ
    MOVEMENT DISORDERS, 1997, 12 (06) : 885 - 897
  • [24] Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
    Lim, Chai K.
    Fernandez-Gomez, Francisco J.
    Braidy, Nady
    Estrada, Cristina
    Costa, Cristina
    Costa, Silvia
    Bessede, Alban
    Fernandez-Villalba, Emiliano
    Zinger, Anna
    Trinidad Herrero, Maria
    Guillemin, Gilles J.
    PROGRESS IN NEUROBIOLOGY, 2017, 155 : 76 - 95
  • [25] Dopamine complexes of iron in the etiology and pathogenesis of Parkinson's disease
    Arreguin, Shelly
    Nelson, Paul
    Padway, Shelby
    Shirazi, Matthew
    Pierpont, Cortlandt
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2009, 103 (01) : 87 - 93
  • [26] The value of NO-system and dopamine in the pathogenesis of Parkinson's disease
    Matmuradov, R. J.
    Matmuradov, R. J.
    Khalimova, Kh.
    Raimova, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 386 - 386
  • [27] Role of dopamine in the pathophysiology of Parkinson's disease
    Zhou, Zhi Dong
    Yi, Ling Xiao
    Wang, Dennis Qing
    Lim, Tit Meng
    Tan, Eng King
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)
  • [28] Role of dopamine in the pathophysiology of Parkinson’s disease
    Zhi Dong Zhou
    Ling Xiao Yi
    Dennis Qing Wang
    Tit Meng Lim
    Eng King Tan
    Translational Neurodegeneration, 12
  • [29] The role of viruses in the pathogenesis of Parkinson's disease
    José Fidel Baizabal-Carvallo
    Marlene Alonso-Juarez
    Neural Regeneration Research, 2021, 16 (06) : 1200 - 1201
  • [30] Role of Lipids in the Pathogenesis of Parkinson's Disease
    Kamano, Shumpei
    Ozawa, Daisaku
    Ikenaka, Kensuke
    Nagai, Yoshitaka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)